| For: | Wang SN, Lee KT, Ker CG. Leptin in hepatocellular carcinoma. World J Gastroenterol 2010; 16(46): 5801-5809 [PMID: 21155000 DOI: 10.3748/wjg.v16.i46.5801] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i46/5801.htm |
| Number | Citing Articles |
| 1 |
Georgina Del Vecchyo-Tenorio, Maricela Rodríguez-Cruz, Adolfo Andrade-Cetto, René Cárdenas-Vázquez. Creosote Bush (Larrea tridentata) Improves Insulin Sensitivity and Reduces Plasma and Hepatic Lipids in Hamsters Fed a High Fat and Cholesterol Diet. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00194
|
| 2 |
Maite Martínez-Uña, Yaiza López-Mancheño, Carlos Diéguez, Manuel A. Fernández-Rojo, Marta G. Novelle. Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases. International Journal of Molecular Sciences 2020; 21(24) doi: 10.3390/ijms21249368
|
| 3 |
Ming‐Jenn Chen, Yao‐Tsung Yeh, King‐Teh Lee, Chia‐Jung Tsai, Hao‐Hsien Lee, Shen‐Nien Wang. The promoting effect of adiponectin in hepatocellular carcinoma. Journal of Surgical Oncology 2012; 106(2) doi: 10.1002/jso.23059
|
| 4 |
Ana Sofia Salsinha, Luís Miguel Rodríguez-Alcalá, Lígia Leão Pimentel, Manuela Pintado. Bioactive Lipids. 2023; doi: 10.1016/B978-0-12-824043-4.00012-9
|
| 5 |
Helen L. Reeves, Marco Y. W. Zaki, Christopher P. Day. Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD. Digestive Diseases and Sciences 2016; 61(5) doi: 10.1007/s10620-016-4085-6
|
| 6 |
Xi Zhou, YanLan Chai, Ke Chen, YunYi Yang, Zi Liu, Erica Villa. A Meta-Analysis of Reference Values of Leptin Concentration in Healthy Postmenopausal Women. PLoS ONE 2013; 8(8) doi: 10.1371/journal.pone.0072734
|
| 7 |
Olivier Rosmorduc, Laetitia Fartoux. Syndrome métabolique, stéatopathie hépatique non alcoolique (NASH) et carcinome hépatocellulaire : des liaisons bien dangereuses.... Bulletin de l'Académie Nationale de Médecine 2014; 198(9) doi: 10.1016/S0001-4079(19)31173-2
|
| 8 |
Noha Mohamed Said, Nahla H. El-Shaer. Association of serum trefoil factor 3 and leptin levels with obesity: A case-control study. Cytokine 2024; 181 doi: 10.1016/j.cyto.2024.156690
|
| 9 |
Shen-Nien Wang, Sen-Te Wang, King Teh Lee. The Potential Interplay of Adipokines with Toll-Like Receptors in the Development of Hepatocellular Carcinoma. Gastroenterology Research and Practice 2011; 2011 doi: 10.1155/2011/215986
|
| 10 |
Winnie-Pui-Pui Liew, Zainuddin Nurul-Adilah, Leslie T. L. Than, Sabran Mohd-Redzwan. The Binding Efficiency and Interaction of Lactobacillus casei Shirota Toward Aflatoxin B1. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.01503
|
| 11 |
Syarminie Subramaniam, Mohd-Redzwan Sabran, Johnson Stanslas, Brian P. Kirby. Effect of aflatoxin B1 exposure on the progression of depressive-like behavior in rats. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1032810
|
| 12 |
Janine Graham, Helen L. Reeves. Non‐Alcoholic Fatty Liver Disease. 2013; doi: 10.1002/9781118556153.ch17
|
| 13 |
Kyle J. Thompson, Ryan Z. Swan, Tracy L. Walling, David A. Iannitti, Iain H. McKillop, David Sindram. Obesity, but not ethanol, promotes tumor incidence and progression in a mouse model of hepatocellular carcinoma in vivo. Surgical Endoscopy 2013; 27(8) doi: 10.1007/s00464-013-2808-8
|
| 14 |
N. Pinheiro-Castro, L. B. A. R. Silva, T. P. Ong. Nutrition and Cancer Prevention. 2019; doi: 10.1039/9781788016506-00147
|
| 15 |
Hamza Chettouh, Marie Lequoy, Laetitia Fartoux, Corinne Vigouroux, Christèle Desbois‐Mouthon. Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. Liver International 2015; 35(10) doi: 10.1111/liv.12903
|
| 16 |
Jian Yang, Jialuo He, Yiting Feng, Ming Xiang. Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1166440
|
| 17 |
Weiqiang Zhou, Yuwang Tian, Hangjun Gong, Shanchun Guo, Chengyu Luo. Oncogenic role and therapeutic target of leptin signaling in colorectal cancer. Expert Opinion on Therapeutic Targets 2014; 18(8) doi: 10.1517/14728222.2014.926889
|
| 18 |
Shanchun Guo, Mingli Liu, Guangdi Wang, Marta Torroella-Kouri, Ruben R. Gonzalez-Perez. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012; 1825(2) doi: 10.1016/j.bbcan.2012.01.002
|
| 19 |
Yiran Bu, Si Chen, Mengcheng Ruan, Libang Wu, Hualin Wang, Na Li, Xiuju Zhao, Xiaoli Yu, Zhiguo Liu. Per1/Per2 double knockout transcriptome analysis reveals circadian regulation of hepatic lipid metabolism. Food Science and Human Wellness 2023; 12(5) doi: 10.1016/j.fshw.2023.02.034
|
| 20 |
Manal M. Hassan, Reham Abdel-Wahab, Ahmed Kaseb, Ahmed Shalaby, Alexandria T. Phan, Hashem B. El-Serag, Ernest Hawk, Jeff Morris, Kanwal Pratap Singh Raghav, Ju-Seog Lee, Jean-Nicolas Vauthey, Gehan Bortus, Harrys A. Torres, Christopher I. Amos, Robert A. Wolff, Donghui Li. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology 2015; 149(1) doi: 10.1053/j.gastro.2015.03.044
|
| 21 |
Sara Salehi Hammerstad, Shira Frankel Grock, Hanna J. Lee, Alia Hasham, Nina Sundaram, Yaron Tomer. Diabetes and Hepatitis C: A Two-Way Association. Frontiers in Endocrinology 2015; 6 doi: 10.3389/fendo.2015.00134
|
| 22 |
Chien-Yu Lin, Pratik Adhikary, Kun Cheng. Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. Advanced Drug Delivery Reviews 2021; 174 doi: 10.1016/j.addr.2021.04.008
|
| 23 |
|
| 24 |
Mei Zhou, Xueyan Wang, Van Phung, Darrin A. Lindhout, Kalyani Mondal, Jer-Yuan Hsu, Hong Yang, Mark Humphrey, Xunshan Ding, Taruna Arora, R. Marc Learned, Alex M. DePaoli, Hui Tian, Lei Ling. Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19. Cancer Research 2014; 74(12) doi: 10.1158/0008-5472.CAN-14-0208
|
| 25 |
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Leptin in nonalcoholic fatty liver disease: A narrative review. Metabolism 2015; 64(1) doi: 10.1016/j.metabol.2014.10.012
|
| 26 |
Neil H. Bhayani, Omar Hyder, Wayne Frederick, Richard D. Schulick, Christopher L. Wolgang, Kenzo Hirose, Barish Edil, Joseph M. Herman, Michael A. Choti, Timothy M. Pawlik. Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis. Surgery 2012; 152(2) doi: 10.1016/j.surg.2012.05.037
|
| 27 |
Chen-Chieh Yang, Shun-Fu Chang, Jian-Kang Chao, Yi-Liang Lai, Wei-En Chang, Wen-Hsiu Hsu, Wu-Hsien Kuo. Activation of AMP-activated protein kinase attenuates hepatocellular carcinoma cell adhesion stimulated by adipokine resistin. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-112
|
| 28 |
Lilong Zhang, Qihang Yuan, Man Li, Dongqi Chai, Wenhong Deng, Weixing Wang. The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: a combination of traditional, survival, and dose-response meta-analysis. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07651-1
|
| 29 |
|
| 30 |
Olivier Rosmorduc. Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: Which clinical arguments?. Annales d'Endocrinologie 2013; 74(2) doi: 10.1016/j.ando.2013.02.008
|
| 31 |
Yusuf Yilmaz, Yasar Colak, Ramazan Kurt, Ebubekir Senates, Fatih Eren. Linking Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: From Bedside to Bench and Back. Tumori Journal 2013; 99(1) doi: 10.1177/030089161309900102
|
| 32 |
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of Diabetes. Clinical Gastroenterology 2018; doi: 10.1007/978-3-319-75856-5_21
|
| 33 |
Wen-Shih Huang, Jen-Tsung Yang, Chien-Chang Lu, Shun-Fu Chang, Cheng-Nan Chen, Yu-Ping Su, Ko-Chao Lee. Fulvic Acid Attenuates Resistin-Induced Adhesion of HCT-116 Colorectal Cancer Cells to Endothelial Cells. International Journal of Molecular Sciences 2015; 16(12) doi: 10.3390/ijms161226174
|
| 34 |
Carlos Jiménez-Cortegana, Alba García-Galey, Malika Tami, Pilar del Pino, Isabel Carmona, Soledad López, Gonzalo Alba, Víctor Sánchez-Margalet. Role of Leptin in Non-Alcoholic Fatty Liver Disease. Biomedicines 2021; 9(7) doi: 10.3390/biomedicines9070762
|
| 35 |
Prashant Kant, Mark A. Hull. Excess body weight and obesity—the link with gastrointestinal and hepatobiliary cancer. Nature Reviews Gastroenterology & Hepatology 2011; 8(4) doi: 10.1038/nrgastro.2011.23
|
| 36 |
Mihaela Aldea, Lucian Craciun, Carmen Crivii. Metformin Impacts the Prognosis of Cancer Patients with Type 2 Diabetes. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2014; 21(2) doi: 10.2478/rjdnmd-2014-0016
|
| 37 |
Nicole M. Kettner, Horatio Voicu, Milton J. Finegold, Cristian Coarfa, Arun Sreekumar, Nagireddy Putluri, Chinenye A. Katchy, Choogon Lee, David D. Moore, Loning Fu. Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis. Cancer Cell 2016; 30(6) doi: 10.1016/j.ccell.2016.10.007
|
| 38 |
Carlos Jiménez-Cortegana, Ana López-Saavedra, Flora Sánchez-Jiménez, Antonio Pérez-Pérez, Jesús Castiñeiras, Juan A. Virizuela-Echaburu, Luis de la de la Cruz-Merino, Víctor Sánchez-Margalet. Leptin, Both Bad and Good Actor in Cancer. Biomolecules 2021; 11(6) doi: 10.3390/biom11060913
|
| 39 |
O. Rosmorduc, L. Fartoux. HCC and NASH: How strong is the clinical demonstration?. Clinics and Research in Hepatology and Gastroenterology 2012; 36(3) doi: 10.1016/j.clinre.2011.12.011
|
| 40 |
Ramy Younes, Elisabetta Bugianesi. The Impact of Metabolic Syndrome on the Outcome of NASH: Cirrhosis, Hepatocellular Carcinoma, and Mortality. Current Hepatology Reports 2018; 17(4) doi: 10.1007/s11901-018-0422-x
|
| 41 |
Qimuge Suyila, Hongwei Cui, Ling Yang, Lingyan Zhao, Ruifang Zhang, Xiulan Su. Serum leptin concentrations in Mongolian women. Obesity Research & Clinical Practice 2013; 7(1) doi: 10.1016/j.orcp.2011.09.002
|
| 42 |
Ali A. Mencin, Joel E. Lavine. Advances in Pediatric Nonalcoholic Fatty Liver Disease. Pediatric Clinics of North America 2011; 58(6) doi: 10.1016/j.pcl.2011.09.005
|
| 43 |
Petra Jackson, Karin S. Hougaard, Ulla Vogel, Dongmei Wu, Lorraine Casavant, Andrew Williams, Mike Wade, Carole L. Yauk, Håkan Wallin, Sabina Halappanavar. Exposure of pregnant mice to carbon black by intratracheal instillation: Toxicogenomic effects in dams and offspring. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2012; 745(1-2) doi: 10.1016/j.mrgentox.2011.09.018
|
| 44 |
Hironori Mizutani, Satoshi Fukushima, Shinichi Masuguchi, Junji Yamashita, Azusa Miyashita, Satoshi Nakahara, Jun Aoi, Yuji Inoue, Masatoshi Jinnin, Hironobu Ihn. Serum levels of leptin receptor in patients with malignant melanoma as a new tumor marker. Experimental Dermatology 2013; 22(11) doi: 10.1111/exd.12238
|
| 45 |
Rong-Rong Song, Xiao-Lin Gu. Serum adiponectin levels may be associated with the pathogenesis of hepatocellular carcinoma. Tumor Biology 2015; 36(4) doi: 10.1007/s13277-014-2931-8
|
| 46 |
Qiqi Yang, Chuan Yan, Xu Wang, Zhiyuan Gong. Leptin induces muscle wasting in kras-driven hepatocellular carcinoma (HCC) model in zebrafish. Disease Models & Mechanisms 2019; doi: 10.1242/dmm.038240
|